We are looking for children 2 to 17 years old to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with pus, weight loss, constant need to poop, frequent fevers and/or canker sores), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe IBD flare-ups? Local research study is testing a potential new medication to see if it may reduce abdominal pain, growth failure, bloody stool, weight loss, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people 2 to 17 years of age to join a CD clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s disease (CD) (including associated symptoms such as swollen joints, unexplained weight loss, diarrhea, chronic fatigue and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for young people 2 to 17 years of age to join a CD study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe ulcerative colitis (including associated symptoms such as abdominal pain and cramps, stomach pain, abdominal pain, weight loss and/or eye pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce abdominal pain, kidney stones, cramps, malnutrition, and/or liver disease associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing CD flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce tiredness, fistula, diarrhea, malnutrition, and/or canker sores associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for child to join a UC clinical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or Crohn’s and UC (including associated symptoms such as cramping, growth failure, constant need to poop, weight loss and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local CD medical research study is testing a potential new medication to see if it may reduce bloody diarrhea, growth failure, bloody stool, malnutrition, and/or canker sores associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the CD medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for young people at least 2 years of age but under 18 to join a clinical research to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or Crohn’s disease (CD) (including associated symptoms such as joint pain, inflammation of the bowel or intestine, bloody stool, frequent fevers and/or eye pain), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce weight loss, weight loss, bloody stool, chronic fatigue, and/or liver disease associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.